Finding New Treatments for People with Rare Illnesses
André Bachmann is creating treatments for children with rare medical conditions that many large pharmaceutical companies won’t develop due to high costs and low returns.
The professor and associate chair for research in the MSU College of Human Medicine and his team are studying the therapeutic potential of existing drugs used to stop cancer growth in children with neuroblastoma — one of the most aggressive forms of pediatric cancer. It’s a novel approach that could lead to similar breakthroughs in medical genetics.
“That really means better treatment and more hope for sick children and their families,” says Bachmann.